Genome-wide association study of recurrent early-onset major depressive disorder
- Shi, J
- Potash, J. B.
- Knowles, J. A.
- Weissman, M. M.
- Coryell, W
- Scheftner, W. A.
- Lawson, W. B.
- DePaulo, J. R.
- Gejman, P. V.
- Sanders, A.R.
- Johnson, J. K.
- Adams, P
- Chaudhury, S
- Jancic, D
- Evgrafov, O
- Zvinyatskovskiy, A
- Ertman, N
- Gladis, M
- Neimanas, K
- Goodell, M
- Hale, N
- Ney, N
- Verma, R
- Mirel, D
- Holmans, Peter Alan
- Levinson, D. F.
DOIAbstract
A genome-wide association study was carried out in 1020 case subjects with recurrent early-onset major depressive disorder (MDD) (onset before age 31) and 1636 control subjects screened to exclude lifetime MDD. Subjects were genotyped with the Affymetrix 6.0 platform. After extensive quality control procedures, 671 424 autosomal single nucleotide polymorphisms (SNPs) and 25 068 X chromosome SNPs with minor allele frequency greater than 1% were available for analysis. An additional 1 892 186 HapMap II SNPs were analyzed based on imputed genotypic data. Single-SNP logistic regression trend tests were computed, with correction for ancestry-informative principal component scores. No genome-wide significant evidence for association was observed,...
Add to ORKG